Naoyuki Ohmura

Recent publications · Crossref

5 total works indexed

1. Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer

   · 2018 · cited 4,585x

2. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

   · 1998 · cited 3,394x

3. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

   · 2018 · cited 3,183x

4. High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis

   · 2001 · cited 2,292x

5. Genetics of rheumatoid arthritis contributes to biology and drug discovery

   · 2013 · cited 2,178x

via Crossref · CC0

Wikidata facts

Image

OB-Naoyuki-Omura20100505.jpg